Celestica (NYSE: CLS) announced the early termination of its existing share repurchase program and the TSX’s acceptance of a new Normal Course Issuer Bid (NCIB). Under the existing program, the company repurchased 2,923,323 shares at an average price of US$43.28. The new NCIB, running from November 1, 2024, to October 31, 2025, allows for the repurchase of up to 8,609,693 common shares, representing 10% of the public float less previously purchased shares. Daily purchases will be to 160,924 shares, based on the average daily trading volume. The program will be funded through existing cash and credit facilities.
Celestica (NYSE: CLS) ha annunciato la cessazione anticipata del suo attuale programma di riacquisto di azioni e l’accettazione da parte della TSX di un nuovo Offerta Normale di Riacquisto di Emittente (NCIB). Sotto l’attuale programma, l’azienda ha…
